Ligocyte Pharmaceuticals - MT Gallatin, Bozeman 59718

Ligocyte Pharmaceuticals entered the industry of Medical Research in 2008 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000.000 to $499.999.999. The NAICS classifies this business under the code 4242101, which describes it as a Medical Research. For further clarification, the SIC classifies this business under the code 8733 and described it as a Medical Research. The business provides service to the B2B market.

To acquire more information, please contact Pat Green, IT Executive by calling (406) 556-9200 during business hours. You can also write to the business’ Single Location at 2155 Analysis Drive, Bozeman, Montana MT 59718. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: Ligocyte Pharmaceuticals
Representative: Pat Green, IT Executive
Place of Business: 2155 Analysis Drive, Bozeman, MT 59718
Contact Number: (406) 556-9200
Type of Service: Medical Research
SIC Number: 8733
NAICS Number: 4242101
Locality: Single Location
Market Type: B2B (Business to Business)
Began: 2008
Income/Year: $100.000.000 to $499.999.999
Laborers: 1 to 4
Share This Company:

Ligocyte Pharmaceuticals is a company operating from Gallatin, Montana providing professional Medical Research and relevant B2B variables. It was founded in 2008 and registered with the SIC code 8733 as Medical Research, and with the NAICS code 4242101 as Medical Research.

With a current employee count of 1 to 4, Ligocyte Pharmaceuticals has gone to report making $100.000.000 to $499.999.999 per annum on its journey towards growth. This company invites you to contact its representative Pat Green, IT Executive at (406) 556-9200 for related queries, or to locate its Single Location using the coordinates 45.66872,-111.06563.

The Single Location can also be found at the street address 2155 Analysis Drive in Bozeman, Montana 59718 and can be engaged online through the company website at , the company Twitter , and Facebook page .